These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34498983)

  • 1. Future perspective: metabolism as a therapeutic target in acute myeloid leukemia - from Warburg to precision medicine.
    Hatfield KJ; Grønningsaeter IS; Reikvam H
    Curr Med Res Opin; 2021 Dec; 37(12):2107-2111. PubMed ID: 34498983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine for acute myeloid leukemia.
    Lai C; Karp JE; Hourigan CS
    Expert Rev Hematol; 2016 Jan; 9(1):1-3. PubMed ID: 26514194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias.
    Anselmi L; Bertuccio SN; Lonetti A; Prete A; Masetti R; Pession A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia.
    Xiao Y; Hu B; Guo Y; Zhang D; Zhao Y; Chen Y; Li N; Yu L
    Curr Treat Options Oncol; 2023 Aug; 24(8):1021-1035. PubMed ID: 37249801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic landscape of acute myelogenous leukemia--moving toward personalized medicine.
    Lamba G; Zaidi SK; Luebbers K; Verschraegen C; Stein GS; Rosmarin A
    J Cell Biochem; 2014 Oct; 115(10):1669-72. PubMed ID: 24905899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.
    Gojo I; Karp JE
    Clin Cancer Res; 2014 Dec; 20(24):6233-41. PubMed ID: 25324141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia.
    Ma J; Ge Z
    Bosn J Basic Med Sci; 2021 Aug; 21(4):409-421. PubMed ID: 33577442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision therapy for acute myeloid leukemia.
    Yang X; Wang J
    J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
    Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
    Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
    Pallarès V; Unzueta U; Falgàs A; Sánchez-García L; Serna N; Gallardo A; Morris GA; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
    J Hematol Oncol; 2020 Apr; 13(1):36. PubMed ID: 32295630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.
    Miyamoto K; Minami Y
    Int J Clin Oncol; 2019 Aug; 24(8):893-898. PubMed ID: 31111287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
    Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
    Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia.
    Ricciardi MR; Mirabilii S; Licchetta R; Piedimonte M; Tafuri A
    Adv Biol Regul; 2017 Aug; 65():36-58. PubMed ID: 28549531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
    Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
    Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic targeting and personalized approaches for AML.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective.
    van Dijk AD; de Bont ESJM; Kornblau SM
    Expert Rev Proteomics; 2020 Jan; 17(1):1-10. PubMed ID: 31945303
    [No Abstract]   [Full Text] [Related]  

  • 19. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE; Ahlers J; Schäfer I; André M; Kerst G; Scheel-Walter HG; Schwarze CP; Pfeiffer M; Lang P; Handgretinger R; Ebinger M
    Pediatr Hematol Oncol; 2011 Mar; 28(2):91-9. PubMed ID: 21214408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia.
    Bajaj J; Konuma T; Lytle NK; Kwon HY; Ablack JN; Cantor JM; Rizzieri D; Chuah C; Oehler VG; Broome EH; Ball ED; van der Horst EH; Ginsberg MH; Reya T
    Cancer Cell; 2016 Nov; 30(5):792-805. PubMed ID: 27908736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.